Kristina Strutt

Publications

180

Citations

H-Index

2001

Active since

Affiliations

Louisville Metabolic and Atherosclerosis Research Center(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

Kristina Strutt is an author at Louisville Metabolic and Atherosclerosis Research Center specializing in cardiovascular disease, medicine, and atherosclerosis.

Top concepts

MedicineAtherosclerosisMetabolic SyndromeCardiovascular DiseasePharmacologyOxidative StressVascular Disease

Publications per year

2001–2003

Publications

Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia

Evan A. Stein, Kristina Strutt, Harry Southworth et al. · The American Journal of Cardiology · 2003 · 106 citations

Metabolic Syndrome, Lipid Disorder, Vascular Disease +7

Randomized Dose-Response Study of Rosuvastatin in Japanese Patients With Hypercholesterolemia

Yasushi Saitō, Yuichiro Goto, Aaron Dane et al. · Journal of Atherosclerosis and Thrombosis · 2003 · 53 citations · Full text

Rosuvastatin (20, 40 and 80 MG) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 and 80 MG) in patients with heterozygous familial hypercholesterolaemia

Evan A. Stein, Kristina Strutt, Elinor Miller · Atherosclerosis Supplements · 2001 · 21 citations

Metabolic Syndrome, Lipid Disorder, Heterozygous Familial Hypercholesterolaemia +9

Rows per page

1–3 of 3